29 Emmons Drive
286 articles with Soligenix
Soligenix to Present at 8th Annual Biotechnology Industry Organization (BIO) Investor Forum Presentation at 1PM PDT, Thursday, October 29, Available by Webcast
Soligenix Announces Initiation of its Confirmatory Phase 3 Clinical Trial of orBec(R) in Acute GI GVHD
DOR BioPharma, Inc. Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SGNX'